We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. According to findings in a recently published study, the ...

Objective: The aim of this study was to assess the clinical effect of antibiotic treatment in a cohort of patients with low-back pain (LBP) and Modic changes Type 1 (bone oedema) following a lumbar ...

The PP353 clinical trial met the primary endpoint and demonstrated statistically significant, clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Researchers found sick-listed low back ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The baseline study population consisted of 75 chronic LBP patients (87% women) with M1 in the lumbar spine. During follow-up, 11 patients were lost as dropouts: seven due to lack of clinical data and ...

London, UK, 11 June 2025 - Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic Low Back Pain (cLBP), today announces ...

Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain The PP353 clinical trial met the ...

Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic low back pain (cLBP), announces positive topline data from its phase ...